NCR1 and nasopharyngeal carcinoma: To further characterize the Ncr1 interactions in the context of lipid metabolism, MYTH analysis was conducted on media supplemented with lipid-regulating drugs that inhibit 2 different features of lipid metabolism, both of which are relevant to NP-C disease with mechanisms of action conserved from yeast to mammalian cells.